Delivery Order SPE2D021DA002-SPE2D325F162R
Award Date 6/24/25
Potential Completion Date 6/27/25
Potential Value $4.9K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,091.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $95,392.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a completion date of June 14, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,454.93 on August 11, 2025, for the supply of Twinrix vaccine syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency, under its Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe form, with a ceiling value of $1,636.62. The contract was awarded on June 27, 2025, with an ultimate completion date of July 2, 2025, and utilizes firm fixed-price pricing with no set-aside designation. Performance will take place at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $16,366.20 firm fixed-price delivery order for Twinrix vaccine syringes by the Defense Logistics Agency's Medical Supply Chain division. The contract, awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,813.04 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Twinrix vaccine syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location with an ultimate completion date of September 8, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...